Education: 

2020-2024: PhD – Immuno-oncology, ” Invalidation of PD-1 and TIGIT in tumor-specific CD8+ T-cells: functional consequences and use in immunotherapy ”, BS Doctoral School, Nantes University, France 

2019-2020: MSc – Biology, Biotechnology and Therapeutic Research, Nantes University, France 

2015-2018: BSc - Cellular and Molecular Biology, Nantes University, France (2015-2017) & Laval University, Québec, Canada (2017-2018) 

Research interests/projects: 

Cancer immunotherapies, engineered TCR therapies, immune checkpoints, CRISPR-Cas9 gene-editing approaches. 

Work experience: 

2025-Present: Postdoc - Development of Cancer Immunotherapy, Department of Cellular Therapy, OUS Radiumhospitalet, Oslo, Norway 

2020-2024: PhD research - “ Invalidation of PD-1 and TIGIT in tumor-specific CD8+ T-cells: functional consequences and use in immunotherapy ”, INCIT Inserm U1302, Nantes University, France 

2019-2020: Internships – 2 master internships, “ Phenotypic and functional characterization of melanoma-specific CD8+ T-cells invalidated for PD-1 and TIGIT expression ”, INCIT Inserm U1302, Nantes University, France 

2017-2018: Internship - Laboratory Technical Platform, Laboratory practice courses in Immunology & Biology, Laval University, Québec, Canada